ChemBioChem · 2015 · 38 citations · 46 references
PharmacyBiochemistryMedicinal ChemistryDrug DesignDrug DiscoveryEnzymologyEnzyme DiscoveryEnzyme InhibitionLigand BindingPeptide Drug DiscoveryPeptidomimetic DesignBicyclic Peptide DesignEnzyme Inhibitor DiscoveryPeptide Medicinal ChemistryProtease Inhibitors
A series of 17 new analogues of trypsin inhibitor SFTI-1 were designed and synthesized to obtain matriptase-2 inhibitors. A number of the modified bicyclic peptides displayed much higher affinity towards matriptase-2 than towards the highly homologous matriptase-1. Replacement of Lys5 by Arg in the wild-type SFTI-1 led to an 11-fold increase in the matriptase-2 inhibitory activity. Replacement of Arg2 by its enantiomer (D-arginine) slightly lowered the inhibition of matriptase-2, but almost completely abolished the affinity towards matriptase-1, thus yielding the most selective matriptase-2 inhibitor. This is the first report describing inhibitors of the recently discovered matriptase-2 based on the SFTI-1 structure. The results showed that SFTI-1 is a promising scaffold for the design of potent and selective inhibitors of this enzyme.
46
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Martin Köbel, Steve E. Kalloger, Niki Boyd et al. · PLoS Medicine · 2008 · 820 citations · Full text
Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)
Karin E. Finberg, Matthew M. Heeney, Dean R. Campagna et al. · Nature Genetics · 2008 · 678 citations · Full text